Search Results
Sep 04, 2026, 22:00 ET Sarepta Therapeutics Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sarepta Therapeutics, Inc. - SRPT
Sarepta Therapeutics, Inc. (NasdaqGS: SRPT) ("Sarepta" or the "Company").
More news about: Kahn Swick & Foti, LLC
May 22, 2026, 11:25 ET Tradr Announces Liquidation of CLSZ, HLXX, MSQ & SRPU
MSQ)Tradr 2X Long SRPT Daily ETF (
More news about: Tradr ETFs
Nov 20, 2025, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT
2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sarepta Therapeutics, Inc. ("Sarepta" or the "Company") (NASDAQ: SRPT). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Oct 23, 2025, 06:46 ET Tradr Debuts Leveraged ETFs on BLSH, DASH, FLY, IREN, NEM, OPEN, QS, SRPT & WULF
Tradr 2X Long SRPT Daily ETF (Cboe: SRPU) – tracks Sarepta Therapeutics, Inc. (Nasdaq: SRPT)
More news about: Tradr ETFs
Oct 21, 2025, 06:46 ET Tradr to Launch Leveraged ETFs on BLSH, DASH, FLY, IREN, NEM, OPEN, QS, SRPT & WULF
QS Daily ETF (Cboe: QSX) – tracks QuantumScape Corporation (NYSE: QS) Tradr 2X Long SRPT Daily ETF (Cboe: SRPU) – tracks Sarepta Therapeutics, Inc. (Nasdaq: SRPT) Tradr 2X Long WULF Daily ETF (Cboe: WULX) – tracks TeraWulf, Inc. (Nasdaq: WULF)
More news about: Tradr ETFs
Sep 24, 2025, 14:10 ET Kuehn Law Encourages Investors of Sarepta Therapeutics, Inc. to Contact Law Firm
Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) breached their fiduciary duties to shareholders.
More news about: Kuehn Law, PLLC
Sep 15, 2025, 08:30 ET Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth
IO Biotech Inc. (NASDAQ: IOBT), Sarepta Therapeutics Inc. (NASDAQ: SRPT), Autolus Therapeutics PLC (NASDAQ: AUTL) and Arcturus Therapeutics Holdings Inc. (NASDAQ:
More news about: NetworkNewsWire